Fludarabine

Myelofibrosis

Center for International Blood and Marrow Transplant ResearchSmall moleculePhase 3Active

B

62/ 100

Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence: 56/ 100
Competitive Position: 73/ 100

Competitive context

47 Active assets in the Myelofibrosis cohort.

Asset / Sponsor	Phase	Rating
Nivestim City of Hope Medical Center	Phase 3	B
Anti-Human T-Lymphocyte Immunoglobulin, Rabbit Fred Hutchinson Cancer Center	Phase 2/3	B
Cyclophosphamide City of Hope Medical Center	Phase 3	B
Alemtuzumab University of Arizona	Phase 2/3	B
Busulfanum City of Hope Medical Center	Phase 2	B

View all 50 →

Same molecule, other indications

Fludarabine is also rated in:

adult T-cell leukemia/lymphomaActive

BBB

Indicative · Phase 2

76 / 100

acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22)Dormant

BBB

Indicative · Phase 2

76 / 100

Fanconi anemiaActive

BBB

Indicative · Phase 2/3

76 / 100

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.